Get the Stockscreener App
9.59
7.43%
-0.77
After Hours:
9.75
0.16
+1.67%
CorMedix Inc Stock (CRMD) Latest News
CorMedix Inc. Announces New Appointments to Senior Leadership Team - ACCESS Newswire
Investor Network: CorMedix Inc. to Host Earnings Call - ACCESS Newswire
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - Simply Wall St
(CRMD) Pivots Trading Plans and Risk Controls - Stock Traders Daily
CorMedix Inc. to Host Seminar on Hemodialysis Catheter Complications at 17th Annual Conference on Nephrology - ACCESS Newswire
CorMedix Inc. to Host Earnings Call - ACCESS Newswire
Analysts Provide An Important Insights On CorMedix Inc (CRMD) - Stocks Register
Elliott Investment Management Buys Wolfspeed Stock, Bets Against Nvidia In Q4 - Benzinga
CorMedix Inc. Announces Resignation of Member of Its Board of Directors - ACCESS Newswire
CorMedix's SWOT analysis: defencath launch propels stock, expansion plans eyed By Investing.com - Investing.com South Africa
CorMedix's SWOT analysis: defencath launch propels stock, expansion plans eyed - Investing.com India
(CRMD) Investment Report - Stock Traders Daily
Top investors say CorMedix Inc (CRMD) ticks everything they need - SETE News
BlackRock, Inc. Increases Stake in Cormedix Inc. - GuruFocus.com
A stock that deserves closer examination: CorMedix Inc (CRMD) - US Post News
D. Boral Capital’s latest rating for CRMD stock - Knox Daily
Daily Progress: CorMedix Inc (CRMD) Drop -6.38, Closing at 10.27 - The Dwinnex
Where are the Opportunities in (CRMD) - Stock Traders Daily
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely - Yahoo Finance
CorMedix Inc. Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities - Marketscreener.com
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities - The Manila Times
CorMedix Partners with WSI PBG to Bring DefenCath to 40,000 Veterans with Kidney Disease - StockTitan
Trading (CRMD) With Integrated Risk Controls - Stock Traders Daily
CorMedix Partners With WSI PBG To Improve Access To DefenCath For ESRD Patients - Nasdaq
Boral Capital sets CorMedix stock target, Buy rating on potential By Investing.com - Investing.com Australia
Boral Capital sets CorMedix stock target, Buy rating on potential - Investing.com
I’m (Finally) a Believer in This Low-Priced Biotech - TheStreet
CorMedix Stock Rises on Q4 Preliminary Sales Beating Estimates - MSN
CorMedix soars on Q4 preliminary results, business updates - MSN
CorMedix stock soars on preliminary Q4 revenue beat - Investing.com India
CorMedix Soars 32% on Upbeat Q4 Forecast - Wall Street Pit
CorMedix Shares Rise 21% After Preliminary 4Q Results Beat Estimates - MarketWatch
CorMedix: Finally In Commercialization Mode (NASDAQ:CRMD) - Seeking Alpha
CorMedix soars on Q4 preliminary resyults, business updates - MSN
CorMedix stock soars on preliminary Q4 revenue beat By Investing.com - Investing.com Canada
CRMDCorMedix Inc. Latest Stock News & Market Updates - StockTitan
CorMedix soars on Q4 preliminary results, business updates (CRMD:NASDAQ) - Seeking Alpha
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update - The Manila Times
CorMedix reports preliminary Q4 net revenue $31M - TipRanks
CorMedix Hits Breakeven Target with $31M Q4 Revenue, Secures $25M in New Orders for DefenCath - StockTitan
Is CorMedix (CRMD) Stock Outpacing Its Medical Peers This Year? - MSN
CorMedix price target raised to $12 from $11 at RBC Capital - Yahoo Finance
RBC optimistic on CorMedix shares as DefenCath launch gains traction in outpatient - Investing.com India
CorMedix's SWOT analysis: defencath launch boosts stock amid expansion plans By Investing.com - Investing.com South Africa
CorMedix's SWOT analysis: defencath launch boosts stock amid expansion plans - Investing.com Australia
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):